J Infect Dis. 2007 Mar 15;195(6):833-6. Epub 2007 Jan 30.

Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.

Siliciano JD, Lai J, Callender M, Pitt E, Zhang H, Margolick JB, Gallant JE, Cofrancesco J Jr, Moore RD, Gange SJ, Siliciano RF.

Source

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. rsiliciano@jhmi.edu

Abstract

In light of a recent report that short-term treatment with valproic acid (VA) might accelerate the decay of the latent reservoir for HIV-1 in patients receiving combination therapy and allow eventual eradication of the infection, we studied patients with prolonged suppression of viremia who were receiving combination therapy and who had also been receiving chronic VA therapy for neurological or psychiatric conditions. Latently infected cells were readily detected in all patients at levels comparable to those seen in patients receiving combination therapy alone. We conclude that the clinical use of VA has no ancillary effect on the decay of the latent reservoir.

Comment in

J Infect Dis. 2007 Mar 15;195(6):770-2.

PMID:: 17299713; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Valproic Acid

Grant Support

AI43222/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

VALPROIC ACID - HSDB

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir. [AIDS. 2008]
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.
Sagot-Lerolle N, Lamine A, Chaix ML, Boufassa F, Aboulker JP, Costagliola D, Goujard C, Pallier C, Delfraissy JF, Lambotte O, et al. AIDS. 2008 Jun 19; 22(10):1125-9.
Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART. [PLoS Pathog. 2007]
Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
Sedaghat AR, Siliciano JD, Brennan TP, Wilke CO, Siliciano RF. PLoS Pathog. 2007 Aug 31; 3(8):e122.
Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART. [BMC Infect Dis. 2008]
Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
Sedaghat AR, Siliciano RF, Wilke CO. BMC Infect Dis. 2008 Jan 2; 8:2. Epub 2008 Jan 2.
Review The challenge of viral reservoirs in HIV-1 infection. [Annu Rev Med. 2002]
Review The challenge of viral reservoirs in HIV-1 infection.
Blankson JN, Persaud D, Siliciano RF. Annu Rev Med. 2002; 53:557-93.
Review Potential role of immune modulation in the effective long-term control of HIV-1 infection. [J Biol Regul Homeost Agents. 2002]
Review Potential role of immune modulation in the effective long-term control of HIV-1 infection.
Rizzardi GP, Lazzarin A, Pantaleo G. J Biol Regul Homeost Agents. 2002 Jan-Mar; 16(1):83-90.

See reviews... See all...

Cited by 29 PubMed Central articles

HIV Latency. [Cold Spring Harb Perspect Med. 2011]
HIV Latency.
Siliciano RF, Greene WC. Cold Spring Harb Perspect Med. 2011 Sep; 1(1):a007096.
Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors. [Virol J. 2011]
Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors.
Sahu GK, Cloyd MW. Virol J. 2011 Aug 12; 8:400. Epub 2011 Aug 12.
Review Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir. [Mol Med. 2011]
Review Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.
Matalon S, Rasmussen TA, Dinarello CA. Mol Med. 2011 May-Jun; 17(5-6):466-72. Epub 2011 Mar 15.

See all...

Chemical compound information

Valproic Acid

MW: 144.21 g/mol

MF: C₈H₁₆O₂

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.
J Infect Dis. 2007 Mar 15 ;195(6):833-6. Epub 2007 Jan 30 .

PubMed
How to engage Cofilin.
How to engage Cofilin.
Retrovirology. 2008 Sep 22 ;5:85.

PubMed
The origins of acquired immune deficiency syndrome viruses: where and when?
The origins of acquired immune deficiency syndrome viruses: where and when?
Philos Trans R Soc Lond B Biol Sci. 2001 Jun 29 ;356(1410):867-76.

PubMed
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the...
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
Nature. 2002 Aug 8 ;418(6898):646-50. Epub 2002 Jul 14 .

PubMed
Viral load and heterosexual transmission of human immunodeficiency virus type 1....
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.
N Engl J Med. 2000 Mar 30 ;342(13):921-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: